arrow
T

Thomas Kruse

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
H指数:16
被引数:625

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

安全性、耐受性、药代动力学和药效学:一种首创的GLP-1和胰高血糖素样肽-1受体激动剂,amycretin:一项首次人体、1期、双盲、随机、安慰剂对照试验

2025-06-200
PRE
Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
2022-12-0111
OAAI